Effect of KB003 in Subjects With Asthma Inadequately Controlled by Corticosteroids

Completed · Phase 2 · Has a placebo group

Conditions studied: Moderate-to-Severe Asthma

In brief

This study will evaluate the safety, tolerability and efficacy of a single dose level of KB003 in subjects with inadequately controlled asthma.

Key facts

Study ID: NCT01603277
Run by: Humanigen, Inc.
People needed: 160
Starts: 2012-07-01
Expected to finish: 2014-01-01
Last updated by the study team: 2015-02-02

Who can join

Age: 16 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

Where it is running

Study site — Fullerton, California, United States
Study site — Granada Hills, California, United States
Study site — Los Angeles, California, United States
Study site — Rancho Mirage, California, United States
Study site — Sacramento, California, United States
Study site — San Jose, California, United States
Study site — Centennial, Colorado, United States
Study site — Colorado Springs, Colorado, United States
Study site — Denver, Colorado, United States
Study site — Waterbury, Connecticut, United States
Study site — Miami, Florida, United States
Study site — Miami, Florida, United States
Study site — Tampa, Florida, United States
Study site — Winter Park, Florida, United States
Study site — Duluth, Georgia, United States
Study site — Lawrenceville, Georgia, United States
Study site — Savannah, Georgia, United States
Study site — Lexington, Kentucky, United States
Study site — Ann Arbor, Michigan, United States
Study site — St Louis, Missouri, United States
Study site — Reno, Nevada, United States
Study site — Summit, New Jersey, United States
Study site — Winston-Salem, North Carolina, United States
Study site — Oklahoma City, Oklahoma, United States
Study site — Birmingham, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.